On Tuesday, the stock price of Japan Tobacco Inc. decreased by 0.9%. The stock reached a low trading price of $12.87 and closed at $12.90. Approximately 39,332 shares were traded during the reporting period, representing a 25% decrease compared to the average daily trading volume of 52,106 shares. The previous closing price of the stock was $13.02.
According to reports, The Goldman Sachs Group has initiated its coverage on Japan Tobacco on October 4th, issuing a "hold" rating for the company.
The company has a quick ratio of 1.39, a current ratio of 1.90, and a debt-to-capital ratio of 0.24. Their 50-day moving average price stands at $11.95, while the 200-day moving average price is $11.33.
The company announced its earnings data for the previous quarter on October 31st. The earnings per share for the company in the last quarter were $0.30. The company's revenue for the previous quarter was $5.29 billion. Japan Tobacco's return on equity was reported at 12.44%, with a net profit margin of 17.21%. On average, sell-side analysts forecast that Japan Tobacco Corporation will achieve earnings per share of $0.88 in the current fiscal year.
Japan Tobacco Inc. is a tobacco company engaged in the production and sale of tobacco products, pharmaceutical products, and processed foods. It operates both in Japan and globally. The company conducts its business in the fields of tobacco, pharmaceuticals, and processed foods. Its product lineup includes cigarettes, non-combustible tobacco products, e-cigarettes, sliced tobacco, cigars, pipes, smokeless tobacco products, and hookahs, among others.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
